Sudha Krishnan

Sudha Krishnan is a seasoned professional in business development within the biopharmaceutical industry, currently serving as Vice President of Business Development at Abzena since October 2023. Previously, Sudha held the position of Director of US Business Development for Cell and Gene Therapy at Pharmaron from January to October 2023, contributing to end-to-end CRO services. Sudha's earlier experience includes roles at Synthego Corporation, where responsibilities ranged from Senior Clinical Sales Specialist to Strategic Account Manager, focusing on genome engineering with CRISPR technology. Sudha also achieved significant success at Advanced Cell Diagnostics as an Account Manager and Inside Sales Manager. Prior to these positions, Sudha gained research experience at AbbVie and Massachusetts General Hospital. Sudha holds a PhD in Cell and Molecular Biology from the University of Massachusetts Amherst and a Bachelor's degree in Biochemistry from the University of Madras.